References
- Friedman M, Manwaring JH, Rosenman RH, et al. Instantaneous and sudden deaths: critical and pathological differentiation in coronary artery disease. JAMA 1973: 225(11): 1319–28
- Myerburg RJ, Conde CA, Sung RJ, et al. Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med 198068(4): 568–76
- Cobb LA, Baum RS, Alvarez H 3d, et al. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation 1975: 52(6 Suppl 3): 223–25
- Schaffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med 1975: 293(6): 259–62
- Ruskin JN, DiMarco JP, Garan H. Out-of-hospital cardiac arrest electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 1980: 303(11)307–13
- Benditt DG, Benson DW Jr, Klein GJ, et al. Prevention of recurrent sudden cardiac arrest: role of provocative electropharmacologic testing. J Am Coll Cardiol 1983: 2(3): 418–25
- Josephson ME, Horowitz LN, Spielman SR, et al. Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest Am J Cardiol 1980: 46(6): 948–55
- Roy D, Waxman HL, Kienzle MG, et al. Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest relation to inducibility at electrophysiologic testing. Am J Cardiol 1983: 52(8): 969–74
- Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation 1978: 57(3): 431–40
- Mason JW, Winkle RA. Accuracy of ventricular tachycardia-induction study far predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med 1980: 303(19): 1073–7
- Horowitz LN, Josephson ME, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 1978: 58(6): 986–97
- Mason JW, Winkle RA. Electrode-catheter arrhythmia Induction in the selection and assessment of antiarrhythmic drug therapy far recurrent ventricular tachycardia. Circulation 1978: 58(6)971–85
- Kapoor WN, Karpf M, Wieand S, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983: 309(4): 197–204
- DiMarco JP, Garan H, Harthorne JW, et al. Intracardiac electrophysiologic techniques In recurrent syncope of unknown cause. Ann Intern Med 1981: 95(5): 542–8
- Morady F, Shen E, Schwartz A, et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol 1983: 2(6): 1053–9
- Akhtar M, Shenasa M, Denker S, et al. Role of cardiac electrophysiologic studies in patients with unexplained recurrent syncope. PACE 1963: 6(2 Pt 1): 192–201
- Gulamhusein S, Naccarelli GV, Ko PT, et al. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med 1982: 73(5): 700–5
- Klein GJ, Gulamhusein SS. Intermittent preexcitation in the Wolf-Parkinson-White syndrome. Am J Cardiol 1983: 52(3)292–6
- Wellens HJ, Braat S, Brugada P, et al. Use of procainamide in patients with Wolf-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol 1982: 50(5): 1087–9
- Wellens HJ, Bar FW, Dassen WR, et al. Effect of drugs in the Wolf-Parkinson-White syndrome: importance of initial length of effective refractory period of the accessory pathway. Am J Cardiol 1980: 46(4)665–9